MedPath

Nervcedil

Brand Name: Nervcedil

Generic Name: Citicoline

Active
Registration Number

DR-XY47862

Dosage Form

Solution for Injection (IV/IM)

Issuance Date

March 31, 2022

Expiry Date

March 31, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength250 mg/mL (1 g/4 mL)
Packaging4 mL USP Type I clear glass ampoule (Box of 5's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Other Psychostimulants and Nootropics
A
Application
Initial
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

CiticolineActive
Monograph: Citicoline

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform